✨ Medicines Distribution Consent




NEW ZEALAND GAZETTE

No. 7

Consent to the Distribution of a Changed Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Xeloda

Active Ingredient:
Capecitabine 150mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturer(s):
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited (trading as Roche Consumer Health), Welwyn Garden City, Hertfordshire, United Kingdom

Note: This product has consent that expires on 5 August 2003.

Product:
Xeloda

Active Ingredient:
Capecitabine 500mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturer(s):
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited (trading as Roche Consumer Health), Welwyn Garden City, Hertfordshire, United Kingdom

Note: This product has consent that expires on 5 August 2003.

Dated this 16th day of January 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go562

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Methotrexate Onco-Vial

Active Ingredient:
Methotrexate 100mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia

Product:
Methotrexate Onco-Vial

Active Ingredient:
Methotrexate 25mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia

Product:
Methotrexate

Active Ingredient:
Methotrexate 25mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia

Product:
Methotrexate

Active Ingredient:
Methotrexate 100mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia

Product:
Methotrexate

Active Ingredient:
Methotrexate 10mg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Baxter Healthcare Limited

Manufacturer:
David Bull Laboratories Limited, Mulgrave North, Victoria, Australia



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 7


Gazette.govt.nz PDF NZ Gazette 2002, No 7





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of Changed Medicine

πŸ₯ Health & Social Welfare
16 January 2002
Medicine, Distribution Consent, Xeloda, Capecitabine, Roche Products
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution Consent, Methotrexate, Baxter Healthcare